It has also been shown that a point mutation in the predicted Bcr-Abl DH domain (S509A) that was proposed to lack GEF activity was able to induce leukemia with shorter latency as compared to wild-type p210 in a mouse model13. This evidence concerns the gene EVPL and leukemia.